Cargando…
The global change of gene expression pattern caused by PTEN mutation affects the prognosis of glioblastoma
Glioblastoma (GBM), an aggressive primary tumor, is common in humans, accounting for 12–15% of all intracranial tumors, and has median survival of fewer than 15 months. Since a growing body of evidence suggests that conventional drugs are ineffective against GBM, our goal is to find emerging therapi...
Autores principales: | Zhou, Shengjun, Wang, Haifeng, Huang, Yi, Wu, Yiwen, Lin, Zhiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396408/ https://www.ncbi.nlm.nih.gov/pubmed/36016609 http://dx.doi.org/10.3389/fonc.2022.952521 |
Ejemplares similares
-
Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma
por: Fan, Caibin, et al.
Publicado: (2019) -
TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
por: Zhang, Yufeng, et al.
Publicado: (2022) -
MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells
por: Zhu, Yan, et al.
Publicado: (2021) -
Microglia-Specific Expression of HEXA and HEXB Leads to Poor Prognosis in Glioblastoma Patients
por: Jia, Mengxian, et al.
Publicado: (2021) -
Focus on PTEN Regulation
por: Bermúdez Brito, Miriam, et al.
Publicado: (2015)